Approval · Notice of Compliance 20587 · 2018
CYCLOBENZAPRINE: Notice of Compliance 20587
Issued March 7, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20587
- Date
- March 7, 2018
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Labelling update to match licensor
- Canadian reference product
- APO-CYCLOBENZAPRINE (Apotex Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CYCLOBENZAPRINE | Not yet assigned | — |
Medicinal ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE 10 MG per TAB